Site-specific nanomodulator capable of modulation apoptosis for enhanced colorectal cancer chemo-photothermal therapy

Abstract Background Colorectal cancer (CRC) is a common malignancy with the second highest mortality and the third highest morbidity worldwide. However, the overall survival of patients is unsatisfactory, thus requiring more effective clinical strategies. Celastrol (CLT), a natural bioactive compoun...

Full description

Bibliographic Details
Main Authors: Shuqi Wang, Li Zhou, Hailong Tian, Bowen Li, Miao Su, Qiong Li, Edouard C. Nice, Canhua Huang, Jichun Shao, Tao He
Format: Article
Language:English
Published: BMC 2023-01-01
Series:Journal of Nanobiotechnology
Subjects:
Online Access:https://doi.org/10.1186/s12951-023-01779-5
_version_ 1797945771917574144
author Shuqi Wang
Li Zhou
Hailong Tian
Bowen Li
Miao Su
Qiong Li
Edouard C. Nice
Canhua Huang
Jichun Shao
Tao He
author_facet Shuqi Wang
Li Zhou
Hailong Tian
Bowen Li
Miao Su
Qiong Li
Edouard C. Nice
Canhua Huang
Jichun Shao
Tao He
author_sort Shuqi Wang
collection DOAJ
description Abstract Background Colorectal cancer (CRC) is a common malignancy with the second highest mortality and the third highest morbidity worldwide. However, the overall survival of patients is unsatisfactory, thus requiring more effective clinical strategies. Celastrol (CLT), a natural bioactive compound, has been reported to induce reactive oxygen species (ROS)-mediated apoptosis to exhibit significant antitumor effects against CRC. However, the poor water solubility, low targeting ability, and bioavailability of CLT have limited its application, and CLT-induced protective autophagy weakens its therapeutic efficiency. Results We designed a targeted chemo-phototherapy nanoplatform (HCR NPs) to improve the application of CLT. The codelivery of IR820 and CLT in HCR NPs solved the water-soluble problem of CLT and enhanced apoptosis via IR820-mediated hyperthermia. In addition, hydroxychloroquine (HCQ) conjugated to hyaluronic acid (HA) not only increased the active targeting of HCR NPs but also inhibited CLT-induced protective autophagy to exacerbate apoptosis, thus achieving an amplified antitumor effect. Importantly, the HCR NPs exhibited an excellent therapeutic effect on CRC both in vitro and in vivo. Conclusion The HCR NPs presented in this study may not merely provide a new reference for the clinical application of CLT but also result in an attractive strategy for CRC treatment.
first_indexed 2024-04-10T21:00:25Z
format Article
id doaj.art-d92835118d3e4206b41a2574a29ee11f
institution Directory Open Access Journal
issn 1477-3155
language English
last_indexed 2024-04-10T21:00:25Z
publishDate 2023-01-01
publisher BMC
record_format Article
series Journal of Nanobiotechnology
spelling doaj.art-d92835118d3e4206b41a2574a29ee11f2023-01-22T12:24:00ZengBMCJournal of Nanobiotechnology1477-31552023-01-0121111510.1186/s12951-023-01779-5Site-specific nanomodulator capable of modulation apoptosis for enhanced colorectal cancer chemo-photothermal therapyShuqi Wang0Li Zhou1Hailong Tian2Bowen Li3Miao Su4Qiong Li5Edouard C. Nice6Canhua Huang7Jichun Shao8Tao He9Institute for Cancer Medicine, School of Basic Medical Sciences, Southwest Medical UniversityKey Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, the Second Affiliated Hospital, Chongqing Medical UniversityState Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and West China, School of Basic Medical Sciences and Forensic Medicine, Collaborative Innovation Center for Biotherapy, Sichuan UniversityState Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and West China, School of Basic Medical Sciences and Forensic Medicine, Collaborative Innovation Center for Biotherapy, Sichuan UniversityState Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and West China, School of Basic Medical Sciences and Forensic Medicine, Collaborative Innovation Center for Biotherapy, Sichuan UniversityState Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and West China, School of Basic Medical Sciences and Forensic Medicine, Collaborative Innovation Center for Biotherapy, Sichuan UniversityDepartment of Biochemistry and Molecular Biology, Monash UniversityState Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and West China, School of Basic Medical Sciences and Forensic Medicine, Collaborative Innovation Center for Biotherapy, Sichuan UniversityThe Second Affiliated Hospital of Chengdu Medical College, China National Nuclear Corporation 416 HospitalInstitute for Cancer Medicine, School of Basic Medical Sciences, Southwest Medical UniversityAbstract Background Colorectal cancer (CRC) is a common malignancy with the second highest mortality and the third highest morbidity worldwide. However, the overall survival of patients is unsatisfactory, thus requiring more effective clinical strategies. Celastrol (CLT), a natural bioactive compound, has been reported to induce reactive oxygen species (ROS)-mediated apoptosis to exhibit significant antitumor effects against CRC. However, the poor water solubility, low targeting ability, and bioavailability of CLT have limited its application, and CLT-induced protective autophagy weakens its therapeutic efficiency. Results We designed a targeted chemo-phototherapy nanoplatform (HCR NPs) to improve the application of CLT. The codelivery of IR820 and CLT in HCR NPs solved the water-soluble problem of CLT and enhanced apoptosis via IR820-mediated hyperthermia. In addition, hydroxychloroquine (HCQ) conjugated to hyaluronic acid (HA) not only increased the active targeting of HCR NPs but also inhibited CLT-induced protective autophagy to exacerbate apoptosis, thus achieving an amplified antitumor effect. Importantly, the HCR NPs exhibited an excellent therapeutic effect on CRC both in vitro and in vivo. Conclusion The HCR NPs presented in this study may not merely provide a new reference for the clinical application of CLT but also result in an attractive strategy for CRC treatment.https://doi.org/10.1186/s12951-023-01779-5Colorectal cancerCelastrolIR820ChemotherapyPhotothermal therapy
spellingShingle Shuqi Wang
Li Zhou
Hailong Tian
Bowen Li
Miao Su
Qiong Li
Edouard C. Nice
Canhua Huang
Jichun Shao
Tao He
Site-specific nanomodulator capable of modulation apoptosis for enhanced colorectal cancer chemo-photothermal therapy
Journal of Nanobiotechnology
Colorectal cancer
Celastrol
IR820
Chemotherapy
Photothermal therapy
title Site-specific nanomodulator capable of modulation apoptosis for enhanced colorectal cancer chemo-photothermal therapy
title_full Site-specific nanomodulator capable of modulation apoptosis for enhanced colorectal cancer chemo-photothermal therapy
title_fullStr Site-specific nanomodulator capable of modulation apoptosis for enhanced colorectal cancer chemo-photothermal therapy
title_full_unstemmed Site-specific nanomodulator capable of modulation apoptosis for enhanced colorectal cancer chemo-photothermal therapy
title_short Site-specific nanomodulator capable of modulation apoptosis for enhanced colorectal cancer chemo-photothermal therapy
title_sort site specific nanomodulator capable of modulation apoptosis for enhanced colorectal cancer chemo photothermal therapy
topic Colorectal cancer
Celastrol
IR820
Chemotherapy
Photothermal therapy
url https://doi.org/10.1186/s12951-023-01779-5
work_keys_str_mv AT shuqiwang sitespecificnanomodulatorcapableofmodulationapoptosisforenhancedcolorectalcancerchemophotothermaltherapy
AT lizhou sitespecificnanomodulatorcapableofmodulationapoptosisforenhancedcolorectalcancerchemophotothermaltherapy
AT hailongtian sitespecificnanomodulatorcapableofmodulationapoptosisforenhancedcolorectalcancerchemophotothermaltherapy
AT bowenli sitespecificnanomodulatorcapableofmodulationapoptosisforenhancedcolorectalcancerchemophotothermaltherapy
AT miaosu sitespecificnanomodulatorcapableofmodulationapoptosisforenhancedcolorectalcancerchemophotothermaltherapy
AT qiongli sitespecificnanomodulatorcapableofmodulationapoptosisforenhancedcolorectalcancerchemophotothermaltherapy
AT edouardcnice sitespecificnanomodulatorcapableofmodulationapoptosisforenhancedcolorectalcancerchemophotothermaltherapy
AT canhuahuang sitespecificnanomodulatorcapableofmodulationapoptosisforenhancedcolorectalcancerchemophotothermaltherapy
AT jichunshao sitespecificnanomodulatorcapableofmodulationapoptosisforenhancedcolorectalcancerchemophotothermaltherapy
AT taohe sitespecificnanomodulatorcapableofmodulationapoptosisforenhancedcolorectalcancerchemophotothermaltherapy